COVID-19dermatomyositisinterstitial lung diseaseSARS-CoV-2We read the paper reported by Tam et al. in your journal with great interest. They updated the guidelines of the Asia Pacific League of Associations for Rheumatology on the management of patients with rheumatic and musculoskeletal diseases ...
WEDNESDAY, April 15, 2020 (HealthDay News) -- As the toll of the COVID-19 pandemic grows, it is increasingly clear the infection is more than a lung disease. Many patients are developing heart complications, though the reasons are not fully understood. People with heart disease or a histor...
Scans of patients who were treated in hospital forCOVID-19showed higher rates of damage to the lungs, brain and kidneys compared with the non-COVID control group. Lung injuries were almost 14 times higher among long COVID patients, while abnormal findings involving the brain and kidneys ...
NyQuil is used to treat cold and flu symptoms like cough, fever or headache. It is not used to kill the COVID-19 virus. If you test positive for COVID-19 and have certain health conditions that increase your risk of becoming very sick (for example: lung disease, heart disease, obesity...
COVID-19patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress.[1] ...
A lung infection – which is what pneumonia is – can make your air sacs fill up with fluid or pus. You may cough up a lot of green or yellow mucus. It may have blood in it. Usually, bacteria cause pneumonia. But fungal orviral infections, like the flu and COVID-19, can bring ...
Official answer: People who are deficient in vitamin C could be more at risk of SARS-CoV-2, or of developing severe COVID-19 because...
COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress. ...
"Studying these samples [from patients who died after being infected by the ancestral strain in the pre-vaccine phase] is very important to help us understand themolecular mechanismsinvolved in fatal cases of COVID-19." The findings also show why there are so many clinical variations in severe...
Insights of How Lung Microbiome can Contribute to COVID-19 Severity in Intensive Care Unit Patientsdoi:10.35248/2157-7560.21.12.450Annabelle Lemenuel-DiotBarry ClinchAeron C. HurtPaul BoutryJohann LaurentMathias LeddinStefan FringsJean Eric Charoin...